• Users Online: 129
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Itraconazole: What clinicians should know?

De Doncker Piet, Pande Sushil, Richarz Ute, Garodia Nishant

Year : 2017| Volume: 3| Issue : 1 | Page no: 4-10

   This article has been cited by
1 Preparation of Topical Itraconazole with Enhanced Skin/Nail Permeability and In Vivo Antifungal Efficacy against Superficial Mycosis
Laxman Subedi,Seung-Yub Song,Saurav Kumar Jha,Sung-Ho Lee,Rudra Pangeni,Kyo-Tan Koo,Beum Joon Kim,Seung-Sik Cho,Jin Woo Park
Pharmaceutics. 2021; 13(5): 622
[Pubmed]  [Google Scholar] [DOI]
2 In vitro activity of itraconazole against SARS-CoV-2
Ellen Van Damme,Sandra De Meyer,Denisa Bojkova,Sandra Ciesek,Jindrich Cinatl,Steven De Jonghe,Dirk Jochmans,Pieter Leyssen,Christophe Buyck,Johan Neyts,Marnix Van Loock
Journal of Medical Virology. 2021; 93(7): 4454
[Pubmed]  [Google Scholar] [DOI]
3 Gender differences in concentration of itraconazole and hydroxyitraconazole
Tijana Stanojkovic,Milijana Miljkovic,Nemanja Rancic,Aleksandra Kovacevic,Viktorija Dragojevic-Simic
Halo 194. 2021; 27(1): 7
[Pubmed]  [Google Scholar] [DOI]
4 “Azole menace”-An underappreciated trigger perpetuating the epidemic of antifungal therapeutic failure in cutaneous mycoses
Sidharth Sonthalia,Amarendra Pandey,Ruchika Mehndiratta,Mahima Agrawal,Shukla Das,Shrishti Shreshtha
Dermatologic Therapy. 2021;
[Pubmed]  [Google Scholar] [DOI]
5 Antifungal agents and the kidney: pharmacokinetics, clinical nephrotoxicity, and interactions
Athanasios Tragiannidis,Anastasia Gkampeta,Maria Vousvouki,Eleni Vasileiou,Andreas H. Groll
Expert Opinion on Drug Safety. 2021; : 1
[Pubmed]  [Google Scholar] [DOI]
6 Dissolving microneedle-mediated dermal delivery of itraconazole nanocrystals for improved treatment of cutaneous candidiasis
Andi Dian Permana,Alejandro J. Paredes,Fabiana Volpe-Zanutto,Qonita Kurnia Anjani,Emilia Utomo,Ryan F. Donnelly
European Journal of Pharmaceutics and Biopharmaceutics. 2020; 154: 50
[Pubmed]  [Google Scholar] [DOI]
7 Intrinsic resistance to terbinafine among human and animal isolates of Trichophyton mentagrophytes related to amino acid substitution in the squalene epoxidase
Dominik Lagowski,Sebastian Gnat,Aneta Nowakiewicz,Marcelina Osinska,Mariusz Dylag
Infection. 2020;
[Pubmed]  [Google Scholar] [DOI]
8 Characteristics of Skin Deposition of Itraconazole Solubilized in Cream Formulation
Hyeongmin Kim,Sukkyun Jung,Sooho Yeo,Dohyun Kim,Young Chae Na,Gyiae Yun,Jaehwi Lee
Pharmaceutics. 2019; 11(4): 195
[Pubmed]  [Google Scholar] [DOI]
9 Evaluation of efficacy and safety of oral terbinafine and itraconazole combination therapy in the management of dermatophytosis
Priyanka Sharma,Mala Bhalla,Gurvinder P. Thami,Jagdish Chander
Journal of Dermatological Treatment. 2019; : 1
[Pubmed]  [Google Scholar] [DOI]
10 Antifungal combination therapy in dermatophytosis: a clinical insight
Priyanka Sharma,Mala Bhalla,Gurvinder P. Thami
Journal of Dermatological Treatment. 2019; : 1
[Pubmed]  [Google Scholar] [DOI]
11 Efficacy of oral terbinafine versus itraconazole in treatment of dermatophytic infection of skin – A prospective, randomized comparative study
Anuradha Bhatia,Bimal Kanish,DineshKumar Badyal,Prajakta Kate,Swati Choudhary
Indian Journal of Pharmacology. 2019; 51(2): 116
[Pubmed]  [Google Scholar] [DOI]


Read this article